Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

A recombinant human antithrombin (rhAT; generic name: antithrombin Alfa) has recently been developed. A 37 year-old parturient with hereditary antithrombin deficiency, receiving rhAT infusion therapy, who successfully received an epidural catheter for analgesia and anesthesia during labor and cesarean delivery, is presented. Copyright © 2010 Elsevier Inc. All rights reserved.


Anup Pamnani, Megan Rosenstein, Alaeldin Darwich, Alexander Wolfson. Neuraxial anesthesia for labor and cesarean delivery in a parturient with hereditary antithrombin deficiency on recombinant human antithrombin infusion therapy. Journal of clinical anesthesia. 2010 Sep;22(6):450-3

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 20868967

View Full Text